Why does left ventricular distension usually not occur in veno-arterial extracorporeal membrane oxygenation?

Manoj Myneni; Faisal Cheema; Keshava Rajagopal

doi:10.1101/2022.08.02.22278301

Abstract

Objectives Using a lumped parameter-based theoretical circulatory model, we sought to examine the potential effects of veno-arterial (V-A) extracorporeal membrane oxygenation (ECMO) support on coronary blood flow and resultant left ventricular (LV) contractility.

Background Previous theoretical studies have suggested that V-A ECMO support results in markedly increased left ventricular intracavity pressures and volumes, i.e., not only inadequate unloading, but exacerbated loading. However, this phenomenon of LV distension occurs only uncommonly in clinical scenarios. This discrepancy between previous theoretical work and clinical experience requires explanation.

Methods We defined a piecewise linear relation between the end-systolic pressure and volume of the ventricles to simulate ascending and descending limbs of the Frank-Starling relationship. A linear relationship between coronary blood flow rate and left ventricular contractility was added, defining the so-called “Gregg effect”.

Results LV systolic dysfunction resulted in reduced coronary blood flow; V-A ECMO support augmented coronary blood flow, proportionally to the circuit flow rate. On V-A ECMO support, a weak or absent Gregg effect resulted in increased LV end-diastolic pressures and volumes, and increased end-systolic volume with decreased LV ejection fraction (LVEF), consistent with LV distension. In contrast, a more robust Gregg effect resulted in unaffected and/or even reduced LV end-diastolic pressure and volume, end-systolic volume, and unaffected or even increased LVEF.

Conclusions In this lumped parameter model-based theoretical study, V-A ECMO support was found to augment coronary arterial blood flow. A resultant proportional augmentation of LV contractility may be an important contributory mechanism underlying why LV distension is uncommon in the setting of V-A ECMO support.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

This study did not receive any funding

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes